Pcv-10 Cipla 2,0 μg, 4,0 μg SUSPENSION FOR INJECTION
PDF Leaflet Revision Date: December 2021
Clinical Summary
Quick overview from the medicine insert
Indication
Active immunization against invasive disease caused by Streptococcus pneumoniae in infants and toddlers.
Dosage (summary)
Administered intramuscularly as a three-dose series starting at 6 weeks of age.
Special Populations
- Premature infants
- Children with HIV
- Children with splenic dysfunction
Pregnancy & Breastfeeding
No data available on safety during pregnancy and breastfeeding.
Key Drug Interactions
- Can be co-administered with other vaccines
Contraindications
- Hypersensitivity to any component of the vaccine
Common side effects
- Tenderness at injection site
- Fever
- Irritability
Counselling Points
- Shake well before use
- Inspect for foreign particles before administration
- Monitor for allergic reactions
Serious warnings
- Anaphylaxis risk; adrenaline must be available during vaccination
Important Disclaimer
The Pcv-10 Cipla 2,0 μg, 4,0 μg SUSPENSION FOR INJECTION professional information leaflet below is the property of Cipla Medpro and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
